Literature DB >> 12082491

Hypertension control and medication increase in primary care.

Y Asai1, R Heller, E Kajii.   

Abstract

Over half of treated patients with hypertension are not well controlled. However, little is known about physicians' prescribing behaviour for these patients. Our objective was to clarify whether physicians increase antihypertensive medication in patients with poorly controlled hypertension and what characteristics are predictors of medication increase. This was a retrospective cohort study by surveying medical records in primary care clinics in Tochigi, Japan. Twenty-nine of 79 randomly selected physicians agreed to select 20 consecutive hypertensive patients. This resulted in 547 patients (women 60%; mean (s.d.) age, 68 (12) years) who had blood pressure measurements taken in 1998 and prescription of antihypertensive medication in 1998 and 1999. Mean (s.d.) systolic/diastolic blood pressure was 142 (12)/81 (9) mm Hg and the percentage of patients in good control (<140/90 mm Hg), fair (140-159/90-94) and poor (> or =160/95) were 42%, 47%, and 11%, respectively. Physicians increased medication in 28% of poorly controlled patients (95% confidence interval (CI), 17-41%), which was more than those in fair (12%, 95%CI 8-16%) or good control (7%, 95%CI 4-12%). Multivariate logistic regression analysis showed that systolic and diastolic blood pressures were positively, and the number of kinds of antihypertensive medications and the age of the physician were negatively, associated with an increase in medication. In conclusion, primary care physicians did not increase antihypertensive medication adequately for patients with uncontrolled hypertension. Attempts to understand and to change physicians' prescription behaviour could reduce the burden of uncontrolled hypertension among treated hypertensive patients.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12082491     DOI: 10.1038/sj.jhh.1001385

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  4 in total

1.  Therapy modifications in response to poorly controlled hypertension, dyslipidemia, and diabetes mellitus.

Authors:  Nicolas Rodondi; Tiffany Peng; Andrew J Karter; Douglas C Bauer; Eric Vittinghoff; Simon Tang; Daniel Pettitt; Eve A Kerr; Joe V Selby
Journal:  Ann Intern Med       Date:  2006-04-04       Impact factor: 25.391

2.  Why don't diabetes patients achieve recommended risk factor targets? Poor adherence versus lack of treatment intensification.

Authors:  Julie A Schmittdiel; Connie S Uratsu; Andrew J Karter; Michele Heisler; Usha Subramanian; Carol M Mangione; Joe V Selby
Journal:  J Gen Intern Med       Date:  2008-03-04       Impact factor: 5.128

3.  Treatment intensification and risk factor control: toward more clinically relevant quality measures.

Authors:  Joseph V Selby; Connie S Uratsu; Bruce Fireman; Julie A Schmittdiel; Tiffany Peng; Nicolas Rodondi; Andrew J Karter; Eve A Kerr
Journal:  Med Care       Date:  2009-04       Impact factor: 2.983

4.  Perspectives of patients and physicians regarding hypertensive management from an online survey for excellence: a subanalysis of the PARADOX study by physician categories.

Authors:  Takuo Yoshida; Nobuhiro Nishigaki; Shun Saita; Yukio Shimasaki; Naoyuki Hasebe
Journal:  Hypertens Res       Date:  2020-01-29       Impact factor: 3.872

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.